Abstract
The study includes 102 confirmed cases of carcinoma breast with and without metastasis and 25 healthy non-pregnant females. They were evaluated for blood levels of Ferritin, GSH, LDH, ALP, GGT and Hb before and 21 days after mastectomy. A significant increase (p<0.001) was observed in ferritin, LDH and GSH levels in cancer patients without metastasis in comparison to normal control subjects. Patients with metastasis had further elevated (p<0.001) levels of Ferritin, ALP and GGT as compared to non-metastatic patients. Mastectomy in both the cases i.e. with and without metastasis resulted in non-significant decrease in all the biochemical parameters suggesting that longer follow up could confirm post surgery decrease in the biochemical parameters. The results of the study suggest cost effective, usefulness of Ferritin, ALP, GGT and GSH/Hb ratio in differentiating breast cancer patients with and without metastasis which can be assayed in smaller laboratories.
Similar content being viewed by others
References
Sharma, B.K. and Ray, A. (2000) Breast and Prostate Cancer. IJCB, 15, (Suppl.), 110–17.
Linblom, A. and Liljegreen, A. (2000) Tumor markers in malignancies. B.M.J., 320, 424–27.
Burti’s, C.A. and Ashwood, E.R. (1994) Tietz textbook of clinical chemistry. Second edition, W.B. Saunders Company, Philadelphia pp. 814–15, 813, 848–49, 897–99.
Sadig, R.E.E. and Lai, L.C. (2000) Oestrogens and breast cancer. Clin. Biochemist. Rev. 21, 93–99
Beutler, E. (1971) Red cell metabolism: A manual of biochemical methods. Grune and Stration. New York, 103–5.
Worwood, M. (1986) Serum Ferritin. Clin. Sci. 70, 215–20.
Dacie, J.V. and Lewis, S.M. (1994) Practical haematology, Churchill Livingston, Edinburgh, 8th ed., pp. 49–82.
Guner, G., Kirkali, G., Yenisey, C., Tore, I.R. (1992) Cytosol and Serum ferritin in breast carcinoma. Cancer Lett. Dec. 24, 67 (2–3), 103–12.
Perquin, M., Oster, T., Maul, A., Froment, N., Untereiner, M. and Bagrel, D. (2001) The Glutathione related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features. J. Can. Res. Clin. Oncol. 127(6), 368–74.
Aboughalia, A.H. and Fouad, I.M. (2000) Glutathione and its metabolizing enzymes in patients with different benign and malignant diseases. Clin. Biochem. 33 (8), 657–62.
Kher, A., Maghe, G. and Deshpande, A. (1997) Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breast. Indian J. Pathol. Microbiol. 40 (3), 321–6.
Albuquer que, K.V., Price, M.R., Badley, R.A., Jonrup, I., Pearson, D., Blamey, R.W. and Robertson, J.F. (1995) Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survival. Eur. J. Surg. Oncol. 21(5), 504–9.
Letiagin, V.P. and Vysotskaia, I.V. (1995) Tumor marker CE A, CA 15-3, MCA, TPA, Ferritin and PTH in the diagnosis and monitoring of primary breast cancer. Vestin Ross Akad Med Nauk, 4, 10–14.
Aydiner, A., Topuz, E., Disci, R., Yasasever, V., Dincer, M., Dincol, K. and Bilge, N. (1994) Serum Tumor marker for detection of bone metastasis in breast cancer patients. Acta Oncol, 33 (2), 181–86.
Kokocinska, D., Widala, E., Donocik, J. and Nolewajka, E. (1999) The value of evaluating tumor markers: CA15-3 and ferritin in blood serum of patients grouped as “high risk” for breast cancer. Przegl Lek. 56 (10), 664–67.
Elliott, R.L., Elliott, M.C., Wang, F. and Head, J.F. (1993) Breast carcinoma and the role of iron metabolism. A cytochemical tissue, culture, and ultrastructural study. Ann. N.Y. Acad. Sci. 698, 159–66.
Devlin, T.M. (1997) Textbook of Biochemistry with clinical correlations. Fourth ed. Wiley-Liss. New York p. 484.
Sharabasy, M.M., Dosoky, I., Horia, H. and Khalaf, A.H. (1993) Elevation of glutathione, glutathione reductase and nucleic acids in both normal tissues and tumor of breast cancer patients. Cancer Lett. 72, 11–15.
Murray, G.I., Burke, M.D. and Ewen, S.W.B. (1987) Glutathione localization in benign and malignant human breast lesions. Br. J. Cancer 55, 605–9.
Sieger, S., Bose, C.P., Younes, H., Thies, E., Hoppenkamp, S.R. and Younes, E. (1984) Glutathione and GSH dependent enzymes in the tumours and non-tumours mucosa of the human colon and rectum. J. Cancer Res. Clin. Oncol. 107, 288–340.
Beutler, E. and Gelbart (1985). Plasma glutathione in health and in patients with malignant disease. J. Lab. Clin. Med. 105, 581–84.
Kumaraguruparan, R., Subapriya, R., Kabalimoorthy, J. and Nagini, S. (2002) Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin. Biochem. 35(4), 275–79.
Vaid, P. and Sharma, D.C. (1974) a clinico biochemical study of phosphohexose isomerase, allesterase and SH group. Ind. J. Can. Dec., 448–50.
Vanhoof, V.O., Vanoostrom, A.T., Lepoutre, L.G. and DeBroe, M.E. (1992) Alkaline phosphates isoenzyme patterns in malignancy disease. Clin. Chem. 38, 2546–2551.
Stieber, P., Mangal, D., Ritzke, C., Rossler, N., Kirsch, C.M. and Eiermann, W. (1992) Significance of bone alkaline phosphatase. CA15-3 and CEA in detection of bone metastasis during follow up of patients suffering from breast carcinoma. Eur. J. Clin. Chem. Clin. Biochem. 30, 809–14.
Ramaswamy, G., Rao, V.R., Krishnamoorthy, L., Ramesh, G., Gomathy, R. and Renukadevi, D. (2000) Serum levels of bone alkaline phosphatase in breast and prostate cancer with bone metastasis. Indian J. Clin. Biochem. 15 (2), 110–13.
Lamerz, R., Stieber, P. and Fateh-Moghadam, A. (1993) Serum marker combinations in human breast cancer (review).In Vivo, 7 (613), 607–13.
Sharma, D.C., Mishra, S. and Sharma, P. (2001) Blood Glutathione level in breast cancer patients before and after surgery. J. Obst. Gyn. India. 51 (6), 150–51.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mishra, S., Sharma, D.C. & Sharma, P. Studies of biochemical parameters in breast cancer with and without metastasis. Indian J Clin Biochem 19, 71–75 (2004). https://doi.org/10.1007/BF02872394
Issue Date:
DOI: https://doi.org/10.1007/BF02872394